REVENUE AND ACCOUNTS RECEIVABLE (Tables)

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Revenue

The Company’s revenue streams for the three years ended December 31, 2023, 2022, and 2021 respectively, were as follows:

	Years Ended December 31,
	2023				2022				2021
(in thousands)	Revenue $		Revenue %		Revenue $		Revenue %		Revenue $		Revenue %
Capitated revenue
Medicare	$	2,867,275	91.3	%	$	2,392,445	87.4	%	$	1,334,308	82.9	%
Other capitated revenue	187,137		6.0	%	214,471		7.8	%	194,812		12.1	%
Total capitated revenue	3,054,412		97.3	%	2,606,916		95.2	%	1,529,120		95.0	%
Fee-for-service and other revenue
Fee-for-service	27,704		0.9	%	43,171		1.6	%	25,383		1.6	%
Pharmacy	54,034		1.7	%	50,096		1.8	%	36,306		2.3	%
Other	1,607		0.1	%	38,733		1.4	%	18,560		1.1	%
Total fee-for-service and other revenue	83,345		2.7	%	132,000		4.8	%	80,249		5.0	%
Total revenue	$	3,137,757	100.0	%	$	2,738,916	100.0	%	$	1,609,369	100.0	%

Schedule of Account Receivable Balance

The Company's accounts receivable balances are summarized for the periods indicated below. The Company’s accounts receivable are presented net of the unpaid service provider costs. A right of offset exists when all of the following conditions are met: 1) each of the two parties owed the other determinable amounts; 2) the reporting party has the right to offset the amount owed with the amount owed to the other party; 3) the reporting party intends to offset; and 4) the right of offset is enforceable by law. The Company believes all of the aforementioned conditions existed as of December 31, 2023 and December 31, 2022.

	As of
(in thousands)	December 31, 2023		December 31, 2022
Accounts receivable	$	316,391	$	388,122
Medicare risk adjustment	17,091		49,586
Unpaid service provider costs	(257,681)		(203,892)
Accounts receivable, net	$	75,801	$	233,816

Schedule of Concentration of Risk

	Years Ended December 31,
	2023	2022	2021
Revenues	70.6%	63.7%	59.9%

Those same three payors represented, in aggregate, the following percentages of accounts receivable as of December 31, 2023 and December 31, 2022, respectively.

	As of
	December 31, 2023	December 31, 2022
Accounts receivable, net	75.9%	56.3%